GEN Exclusives

More »

GEN News Highlights

More »
Sep 25, 2007

Eisai to Continue Support of TorreyPines’ Alzheimer’s Target Discovery Work

  • TorreyPines Therapeutics and Eisai extended their collaboration related to discovery of Alzheimer’s targets by a year. The goal of the genetics research is to identify and validate genes associated with the disease.

    Under the terms of the agreement and in connection with the extension, TorreyPines will receive an upfront payment and continued research funding. Eisai will continue to have exclusive rights of first negotiation and refusal for gene targets discovered and validated through the research.

    The companies have a separate partnership to find compounds to treat Alzheimer’s, which was also recently extended.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?